Immune Thrombocytopenia clinical trials at UCSF

• Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

  open to eligible people ages 1-18

  This is an investigator initiated, multicenter, open label, randomized phase 3 study for subjects with newly diagnosed ITP from ages 1 to less than 18 years old.

  San Francisco, California and other locations

Last updated: October 13, 2020